Pediatric Array CGH Analysis ( Cyto–500+ )
Phalanx Biotech collaborated with clinicians and genetic medicine experts in the design and development of pediatric chromosomal microarray to detect DNA microamplification and microdeletions within the full genome. This one microarray provides screening for 500+ hereditary disorders arising from CNVs, and features excellent discriminative power and sensitivity.
Pediatric Array CGH Analysis ( Cyto – 500+ )
Phalanx Biotech collaborated with clinicians and genetic medicine experts in the design and development of pediatric chromosomal microarray to detect DNA microamplification and microdeletions within the full genome. This one microarray provides screening for 500+ hereditary disorders arising from CNVs, and features excellent discriminative power and sensitivity.
Two primary mutations in human genome
Five genetic factors of developmental delay
Integrated genetic disorder testing service
By combining the advantages of “Pediatric Array CGH Analysis ( Cyto - 500+ )” and “Whole Exome Sequencing (WES) for DD/ID”, it is possible to conduct efficient investigation on the cause of disorders including CNVs and SNVs. The result of analysis supports the physician in determining the condition and providing the best management.
Genetic disease testing
Recommended Subjects
- Individuals with clinical manifestation, for example, developmental delay or intellectual disability, who is not otherwise diagnosed.
- Unknown cause, unable to be specified via clinical means, seeks to rule out the possibilities of gene abnormality.
- Familial history of births with other genetic disorder, chromosomal disorder or congenital defect.
Test procedure
- 1The physician collects 1-3 ml blood (or 0.2 ml from baby heel)
- 2Write the consent form
- 3Deliver to laboratory
- 4Laboratory test and data analysis
- 5Report provided by the physician
華聯生技以創新、品質、服務為經營理念，提供全面性的晶片服務
對產品有任何問題皆歡迎提出，我們會盡快與您聯繫！
或洽詢服務專線+886-3-578-1168；0800-777988(按0)，由專人為您提供諮詢！